Titre : Atrophie parodontale

Atrophie parodontale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Transurethral Resection of Prostate

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer l'atrophie parodontale ?

Le diagnostic se fait par un examen clinique et des radiographies dentaires.
Atrophie parodontale Maladies parodontales
#2

Quels tests sont utilisés pour évaluer l'atrophie ?

Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse.
Sondage parodontal Radiographie dentaire
#3

Quels signes cliniques indiquent l'atrophie ?

Les signes incluent la récession gingivale et la mobilité dentaire.
Récession gingivale Mobilité dentaire
#4

L'atrophie parodontale est-elle réversible ?

Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée.
Atrophie parodontale Stabilisation
#5

Quel rôle joue l'historique médical dans le diagnostic ?

L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies.
Antécédents médicaux Facteurs de risque

Symptômes 5

#1

Quels sont les symptômes de l'atrophie parodontale ?

Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine.
Gingivite Halitose
#2

L'atrophie parodontale cause-t-elle des douleurs ?

Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents.
Douleur dentaire Mastication
#3

Peut-on avoir des gencives qui saignent ?

Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire.
Saignement gingival Hygiène bucco-dentaire
#4

Comment l'atrophie affecte-t-elle l'apparence des dents ?

Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale.
Esthétique dentaire Récession gingivale
#5

Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?

Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids.
Sensibilité dentaire Atrophie parodontale

Prévention 5

#1

Comment prévenir l'atrophie parodontale ?

Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles.
Hygiène bucco-dentaire Visites dentaires
#2

Quel rôle joue le brossage des dents ?

Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales.
Plaque dentaire Brossage des dents
#3

Les produits de rinçage buccal sont-ils utiles ?

Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale.
Rinçage buccal Inflammation gingivale
#4

L'alimentation influence-t-elle la santé parodontale ?

Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives.
Nutrition Santé gingivale
#5

Fumer affecte-t-il la santé parodontale ?

Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie.
Tabagisme Maladies parodontales

Traitements 5

#1

Quels traitements sont disponibles pour l'atrophie parodontale ?

Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale.
Détartrage Chirurgie parodontale
#2

La chirurgie est-elle nécessaire pour traiter l'atrophie ?

La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal.
Chirurgie parodontale Restauration
#3

Les antibiotiques sont-ils utilisés dans le traitement ?

Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales.
Antibiotiques Infections parodontales
#4

Comment la thérapie au laser aide-t-elle ?

La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal.
Thérapie au laser Inflammation
#5

Les traitements sont-ils douloureux ?

Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés.
Anesthésie Inconfort dentaire

Complications 5

#1

Quelles complications peuvent survenir avec l'atrophie ?

Les complications incluent la perte de dents, des infections et des problèmes de mastication.
Perte dentaire Infections
#2

L'atrophie parodontale peut-elle affecter la santé générale ?

Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques.
Santé systémique Maladies parodontales
#3

Y a-t-il un risque accru de diabète ?

Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques.
Diabète Contrôle glycémique
#4

Comment l'atrophie affecte-t-elle la qualité de vie ?

Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi.
Qualité de vie Estime de soi
#5

Les infections parodontales peuvent-elles se propager ?

Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques.
Infections Propagation

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire.
Tabagisme Diabète
#2

L'âge influence-t-il le risque d'atrophie ?

Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus.
Âge Usure des tissus
#3

Le stress a-t-il un impact sur la santé parodontale ?

Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales.
Stress Système immunitaire
#4

Les maladies auto-immunes sont-elles un facteur de risque ?

Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale.
Maladies auto-immunes Atrophie parodontale
#5

Une alimentation déséquilibrée influence-t-elle le risque ?

Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie.
Nutrition Santé gingivale
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Atrophie parodontale : Questions médicales les plus fréquentes", "headline": "Atrophie parodontale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Atrophie parodontale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Atrophie parodontale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies parodontales", "url": "https://questionsmedicales.fr/mesh/D010510", "about": { "@type": "MedicalCondition", "name": "Maladies parodontales", "code": { "@type": "MedicalCode", "code": "D010510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Résorption alvéolaire", "alternateName": "Alveolar Bone Loss", "url": "https://questionsmedicales.fr/mesh/D016301", "about": { "@type": "MedicalCondition", "name": "Résorption alvéolaire", "code": { "@type": "MedicalCode", "code": "D016301", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.500" } } }, { "@type": "MedicalWebPage", "name": "Récession gingivale", "alternateName": "Gingival Recession", "url": "https://questionsmedicales.fr/mesh/D005889", "about": { "@type": "MedicalCondition", "name": "Récession gingivale", "code": { "@type": "MedicalCode", "code": "D005889", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.625" } } }, { "@type": "MedicalWebPage", "name": "Perte d'attache parodontale", "alternateName": "Periodontal Attachment Loss", "url": "https://questionsmedicales.fr/mesh/D017622", "about": { "@type": "MedicalCondition", "name": "Perte d'attache parodontale", "code": { "@type": "MedicalCode", "code": "D017622", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C07.465.714.354.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Atrophie parodontale", "alternateName": "Periodontal Atrophy", "code": { "@type": "MedicalCode", "code": "D055093", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Frederik Barkhof", "url": "https://questionsmedicales.fr/author/Frederik%20Barkhof", "affiliation": { "@type": "Organization", "name": "From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden." } }, { "@type": "Person", "name": "Maria Teresa Pellecchia", "url": "https://questionsmedicales.fr/author/Maria%20Teresa%20Pellecchia", "affiliation": { "@type": "Organization", "name": "Department of Medicine, Surgery and Dentistry \"Scuola Medica Salernitana\", Neuroscience Section, University of Salerno, Baronissi, SA, Italy." } }, { "@type": "Person", "name": "Iva Stankovic", "url": "https://questionsmedicales.fr/author/Iva%20Stankovic", "affiliation": { "@type": "Organization", "name": "Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia." } }, { "@type": "Person", "name": "Gregor K Wenning", "url": "https://questionsmedicales.fr/author/Gregor%20K%20Wenning", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } }, { "@type": "Person", "name": "Klaus Seppi", "url": "https://questionsmedicales.fr/author/Klaus%20Seppi", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prostate resection weight matters in severely obstructed men undergoing transurethral resection of the prostate.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35775341", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4081/aiua.2022.2.169" } }, { "@type": "ScholarlyArticle", "name": "Role of Bladder Emptying on Outcomes of Transurethral Resection of the Prostate.", "datePublished": "2023-02-23", "url": "https://questionsmedicales.fr/article/36828265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.urology.2023.02.012" } }, { "@type": "ScholarlyArticle", "name": "Clinical efficacy and complications of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate.", "datePublished": "2023-02-18", "url": "https://questionsmedicales.fr/article/36805825", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40001-023-00989-9" } }, { "@type": "ScholarlyArticle", "name": "The effect of acute urinary retention on the results of transurethral resection of the prostate.", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37491943", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03915603231189627" } }, { "@type": "ScholarlyArticle", "name": "Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36239811", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00345-022-04179-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D009057" }, { "@type": "ListItem", "position": 3, "name": "Maladies de la bouche", "item": "https://questionsmedicales.fr/mesh/D009059" }, { "@type": "ListItem", "position": 4, "name": "Maladies parodontales", "item": "https://questionsmedicales.fr/mesh/D010510" }, { "@type": "ListItem", "position": 5, "name": "Atrophie parodontale", "item": "https://questionsmedicales.fr/mesh/D055093" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Atrophie parodontale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Atrophie parodontale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Atrophie parodontale", "description": "Comment diagnostiquer l'atrophie parodontale ?\nQuels tests sont utilisés pour évaluer l'atrophie ?\nQuels signes cliniques indiquent l'atrophie ?\nL'atrophie parodontale est-elle réversible ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Atrophie parodontale", "description": "Quels sont les symptômes de l'atrophie parodontale ?\nL'atrophie parodontale cause-t-elle des douleurs ?\nPeut-on avoir des gencives qui saignent ?\nComment l'atrophie affecte-t-elle l'apparence des dents ?\nY a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Atrophie parodontale", "description": "Comment prévenir l'atrophie parodontale ?\nQuel rôle joue le brossage des dents ?\nLes produits de rinçage buccal sont-ils utiles ?\nL'alimentation influence-t-elle la santé parodontale ?\nFumer affecte-t-il la santé parodontale ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Atrophie parodontale", "description": "Quels traitements sont disponibles pour l'atrophie parodontale ?\nLa chirurgie est-elle nécessaire pour traiter l'atrophie ?\nLes antibiotiques sont-ils utilisés dans le traitement ?\nComment la thérapie au laser aide-t-elle ?\nLes traitements sont-ils douloureux ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Atrophie parodontale", "description": "Quelles complications peuvent survenir avec l'atrophie ?\nL'atrophie parodontale peut-elle affecter la santé générale ?\nY a-t-il un risque accru de diabète ?\nComment l'atrophie affecte-t-elle la qualité de vie ?\nLes infections parodontales peuvent-elles se propager ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Atrophie parodontale", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'atrophie ?\nLe stress a-t-il un impact sur la santé parodontale ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nUne alimentation déséquilibrée influence-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D055093?mesh_terms=Transurethral+Resection+of+Prostate#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'atrophie parodontale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un examen clinique et des radiographies dentaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'atrophie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des sondages parodontal et des radiographies sont utilisés pour évaluer la perte osseuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent l'atrophie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent la récession gingivale et la mobilité dentaire." } }, { "@type": "Question", "name": "L'atrophie parodontale est-elle réversible ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'atrophie parodontale est généralement irréversible, mais peut être stabilisée." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les facteurs de risque et les antécédents de maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'atrophie parodontale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des gencives enflammées, des douleurs et une mauvaise haleine." } }, { "@type": "Question", "name": "L'atrophie parodontale cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des douleurs lors de la mastication ou de la pression sur les dents." } }, { "@type": "Question", "name": "Peut-on avoir des gencives qui saignent ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les gencives peuvent saigner lors du brossage ou de l'utilisation de fil dentaire." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle l'apparence des dents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner un aspect plus long des dents en raison de la récession gingivale." } }, { "@type": "Question", "name": "Y a-t-il un lien entre l'atrophie et la sensibilité dentaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'atrophie peut augmenter la sensibilité dentaire aux aliments chauds ou froids." } }, { "@type": "Question", "name": "Comment prévenir l'atrophie parodontale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène bucco-dentaire et des visites régulières chez le dentiste sont essentielles." } }, { "@type": "Question", "name": "Quel rôle joue le brossage des dents ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le brossage régulier aide à éliminer la plaque dentaire et à prévenir les maladies parodontales." } }, { "@type": "Question", "name": "Les produits de rinçage buccal sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains rince-bouche antibactériens peuvent aider à réduire l'inflammation gingivale." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la santé parodontale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée riche en vitamines et minéraux favorise la santé des gencives." } }, { "@type": "Question", "name": "Fumer affecte-t-il la santé parodontale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de maladies parodontales et d'atrophie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'atrophie parodontale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent le détartrage, le surfaçage radiculaire et la chirurgie parodontale." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour traiter l'atrophie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie peut être nécessaire dans les cas avancés pour restaurer le tissu parodontal." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils utilisés dans le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antibiotiques peuvent être prescrits pour traiter les infections parodontales." } }, { "@type": "Question", "name": "Comment la thérapie au laser aide-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie au laser peut réduire l'inflammation et favoriser la guérison des tissus parodontal." } }, { "@type": "Question", "name": "Les traitements sont-ils douloureux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent causer un certain inconfort, mais des anesthésiques sont utilisés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'atrophie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de dents, des infections et des problèmes de mastication." } }, { "@type": "Question", "name": "L'atrophie parodontale peut-elle affecter la santé générale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études montrent un lien entre les maladies parodontales et des problèmes systémiques." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de diabète ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies parodontales peuvent aggraver le contrôle glycémique chez les diabétiques." } }, { "@type": "Question", "name": "Comment l'atrophie affecte-t-elle la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des douleurs, des difficultés à manger et une baisse de l'estime de soi." } }, { "@type": "Question", "name": "Les infections parodontales peuvent-elles se propager ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent se propager à d'autres parties du corps, augmentant les risques." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, le diabète, et une mauvaise hygiène bucco-dentaire." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'atrophie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'atrophie parodontale augmente avec l'âge en raison de l'usure des tissus." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur la santé parodontale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut affaiblir le système immunitaire et aggraver les maladies parodontales." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'atrophie parodontale." } }, { "@type": "Question", "name": "Une alimentation déséquilibrée influence-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation pauvre en nutriments peut affaiblir les gencives et favoriser l'atrophie." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 04/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Frederik Barkhof

2 publications dans cette catégorie

Affiliations :
  • From the Department of Neurology and Alzheimer Center (C.G., Y.A.L.P., P.S., W.M.v.d.F., R.O.), and Departments of Radiology and Nuclear Medicine (F.B.) and Epidemiology and Biostatistics (W.M.v.d.F.), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, the Netherlands; Department of Electrical and Computer Engineering (B.T.T.Y., X.Z., N.S.), Clinical Imaging Research Centre, N1 Institute for Health and Memory Networks Program, National University of Singapore; Montreal Neurological Institute (J.W.V.), McGill University, Montreal, Canada; Computer Science and Artificial Intelligence Laboratory (X.Z.), Massachusetts Institute of Technology, Cambridge; Department of Neurology and Neurological Sciences (E.C.M.), Stanford University, CA; Departments of Neurology, Radiology and Biomedical Imaging (B.L.M., H.J.R., R.L.J., G.D.R.), University of California, San Francisco; Institutes of Neurology & Healthcare Engineering (F.B.), University College London, UK; and Clinical Memory Research Unit (R.O.), Lund University, Sweden.

Maria Teresa Pellecchia

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Baronissi, SA, Italy.
Publications dans "Atrophie parodontale" :

Iva Stankovic

2 publications dans cette catégorie

Affiliations :
  • Neurology Clinic, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Publications dans "Atrophie parodontale" :

Gregor K Wenning

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :

Klaus Seppi

2 publications dans cette catégorie

Affiliations :
  • Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Publications dans "Atrophie parodontale" :

Koichi Tabeta

2 publications dans cette catégorie

Affiliations :
  • Division of Periodontology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.

Clemens Walter

2 publications dans cette catégorie

Affiliations :
  • Department of Periodontology, Endodontology and Cariology, University Centre for Dental Medicine, University of Basel, Basel, Switzerland.

Lei Cheng

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Oral Disease, West China Hospital of Stomatology, National Clinical Research Center for Oral Diseases, Sichuan University, Chengdu, China.
Publications dans "Atrophie parodontale" :

Zhixing Deng

1 publication dans cette catégorie

Affiliations :
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Jiaming Li

1 publication dans cette catégorie

Affiliations :
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Yuhao Zhang

1 publication dans cette catégorie

Affiliations :
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Yinian Zhang

1 publication dans cette catégorie

Affiliations :
  • Department of Neuro-Oncological Surgery, Neurosurgery Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China. zyn1007@126.com.

Manuel Paez-Escamilla

1 publication dans cette catégorie

Affiliations :
  • Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :

Hannah L Scanga

1 publication dans cette catégorie

Affiliations :
  • Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :

Alkiviades Liasis

1 publication dans cette catégorie

Affiliations :
  • Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :

Ken K Nischal

1 publication dans cette catégorie

Affiliations :
  • Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Division of Pediatric Ophthalmology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publications dans "Atrophie parodontale" :

Anna Campabadal

1 publication dans cette catégorie

Affiliations :
  • Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
  • Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Publications dans "Atrophie parodontale" :

Alexandra Abos

1 publication dans cette catégorie

Affiliations :
  • Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
Publications dans "Atrophie parodontale" :

Barbara Segura

1 publication dans cette catégorie

Affiliations :
  • Medical Psychology Unit, Department of Medicine, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
  • Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Publications dans "Atrophie parodontale" :

Sources (10000 au total)

Prostate resection weight matters in severely obstructed men undergoing transurethral resection of the prostate.

Transurethral resection of the prostate (TURP) remains one of the goldstandard surgical treatments for benign prostatic hyperplasia/lower urinary tract symptoms. The usefulness of a complete adenoma r... Retrospective analysis of 185 men undergoing TURP in one university hospital. Retrieved data included pre-operative prostate volume and Qmax, as well as resected prostate weight and post-operative Qma... A correlation was found between absolute resected prostate weight and post-operative Qmax in the group of patients with pre-operative Qmax < 10 mL/s (r2 = 0.038, p = 0.032), independently of the pre-o... Patients with pre-operative Qmax ≥ 10 mL/s may do well with less profound prostate resections, whereas patients with lower pre-operative Qmax seem to benefit from a complete adenoma resection....

Role of Bladder Emptying on Outcomes of Transurethral Resection of the Prostate.

To assess the role of bladder emptying on outcomes of males undergoing transurethral resection of the prostate (TURP).... This prospective study involved candidates for TURP (January 2017-2018) with a follow-up of 3 years. Preoperative and follow-up evaluation comprised: UF, simple PVR (S-PVR), PVR-Ratio (PVR-R) as the r... Patients recruited were 100 (mean ± SD age: 68.8 ± 8.7 years). No patient had severe complications, re-admission, nor needed blood transfusion. At baseline, 38% of the patients showed S-PVR ≤ 50 mL, 6... Bladder emptying is only partially related to TURP outcomes and other preperative parameters. Patients with baseline S-PVR lower than 100 mL had the chance of greater recovery of bladder emptying afte...

Clinical efficacy and complications of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate.

Benign prostatic hyperplasia (BPH) is a common disease in elderly males, and many kinds of minimally invasive procedures can be used for the treatment of BPH. However, various procedures have caused s... This study aimed to explore differences of clinical efficacy, surgical features, and complications between transurethral resection of the prostate (TURP) and plasmakinetic enucleation of the prostate ... A total of eligible 850 cases of BPH underwent TURP (the TURP group, 320 cases) or PKEP (the PKEP group, 530 cases) in the urology department of our hospital from March 2015 to 2018 were involved in t... The operative time, intraoperative irrigation volume, postoperative hemoglobin, decrease in hemoglobin, postoperative irrigation time and volume, catheterization time, and hospital stay of the PKEP gr... The clinical efficacy of PKEP is compared favorably with TURP during midterm follow-up. Given the merits such as less blood loss and hospital stay, lower complications, PKEP should be given a priority...

The effect of acute urinary retention on the results of transurethral resection of the prostate.

Acute urinary retention (AUR) is one of the most severe symptoms of Benign Prostatic Hyperplasia (BPH). There are some studies in the literature describing the risk factors for the development of AUR ... Between 2018 and 2020, patients who underwent TUR-P for AUR or lower urinary tract symptoms (LUTS) were included in the study. The inclusion criteria were, men over 50 years old with a BPH diagnosis a... There were 14 and 46 patients for AUR and Elective Groups respectively. The age, pre-operative prostate volume, free and total PSA values, postoperative complication rate, and re-hospitalization rate ... Patients who underwent TUR-P after AUR have a higher risk for complications and re-hospitalization. Care should be taken in these patients and patients should be warned about the risks....

Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study.

To determine the safety and efficacy of transurethral resection of the prostate (TUR-P) in patients 85 years or older.... In this retrospective, multicentre study, patients equal or older than 85 years at the time of surgery (2015-2020) were included. Several pre-, peri- and postoperative parameters were collected. The m... One hundred sixty-eight patients (median age: 87 years, interquartile range [IQR]: 86-89) were recruited. The patients took on average 5.2 permanent medications (3-8), 107 (64%) were anticoagulated pr... This retrospective multicentre study documents the safety and efficacy of TURP (monopolar and bipolar) in the old-old cohort....

Effects of resection volume on postoperative micturition symptoms and retreatment after transurethral resection of the prostate.

Despite advances in technology, such as advent of laser enucleation and minimally invasive surgical therapies, transurethral resection of the prostate (TURP) remains the most widely performed surgical... This observational study used data from patients who underwent TURP at two institutions between January 2011 and December 2021 Data from patients with previous BPH surgical treatment, incomplete data,... In 268 patients without prior BPH medication, there were no differences in prostate volume (PV), transitional zone volume (TZV), or RV according to IPSS. A total of 60 patients started retreatment, in... Maximal TURP leads to improved postoperative outcomes and reduced retreatment rate, it may gradually become a requirement rather than an option....

The Effect of Transurethral Resection of the Prostate on Erectile and Ejaculatory Functions in Patients with Benign Prostatic Hyperplasia.

The aim of this study was to investigate the effect of TURP on erectile function (EF) and ejaculatory function (EJF).... A total of 91 patients who underwent TURP were retrospectively assessed. Patients were divided into two groups based on International Index of Erectile Function (IIEF-5): group A included 41 patients ... In group A, there were no significant statistical differences in mean IIEF-5 at baseline and after TURP 22.88 ± 0.81 versus 22.63 ± 2.63 (p = 0.065). However, in group B, there was significant improve... The results confirmed that TURP has no significant negative influence on EF, and patients with preexisting ED were improved after TURP. On the contrary, the loss of EJF was significant....

Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.

To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla... A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a... Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24... PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...

Risk factors for bladder neck contracture after transurethral resection of the prostate.

Transurethral resection of the prostate (TURP) is the most frequently used treatment of benign prostate hyperplasia with a prostate volume of <80 mL. A long-term complication is bladder neck contractu... We conducted a retrospective analysis of all TURP primary procedures which were performed at one academic institution between 2013 and 2018. All patients were analyzed and compared with regard to post... We included 1368 patients in this analysis. Out of these, 88 patients (6.4%) developed BNC requiring further surgical therapy. The following factors showed a statistically significant association with... BNC is a relevant long-term complication after TURP. In particular, patients with a smaller prostate should be thoroughly informed about this complication....

Safety and efficacy of transurethral holmium laser enucleation of the prostate versus bipolar transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: a prospective randomized controlled trial.

To evaluate the safety and efficacy of transurethral holmium laser enucleation of the prostate (HoLEP) compared to bipolar transurethral resection of the prostate (bTUR-P) in the treatment of benign p... A total of 220 BPH patients hospitalized from January 2022 to September 2023 were included in this study. These patients were randomly assigned to HoLEP and bTUR-P groups, with 110 participants in eac... The baseline characteristics of patients in both groups were similar, with no statistical significance (P > 0.05). Compared to the bTUR-P group, the HoLEP group exhibited significantly less intraopera... After comprehensive evaluation, HoLEP was superior to bTUR-P in terms of safety and efficacy. Therefore, HoLEP may be a preferable choice for the treatment of BPH....